Skip to main content

BioRegion Newsmakers: Jul 10, 2009


Massachusetts Names New Chief Advisor for Business Growth and Development

Michael Hunter has been named Massachusetts undersecretary of business development. He succeeds Gregory Bialecki, who was promoted to the state's secretary of housing and economic development by Gov. Deval Patrick earlier this year after predecessor Daniel O'Connell left state government in a Cabinet shakeup [BRN, Feb. 9].

Hunter will oversee the state offices of business development; travel and tourism; international trade and investment; small business and entrepreneurship; and minority and women business assistance.

Previously, Hunter was director of the business resource team at the state's Executive Office of Housing and Economic Development. Before re-joining state government, he was an assistant vice president at DMJM/Harris, a firm specializing in transportation and infrastructure, where he managed mixed use real estate projects. Earlier, he was real estate manager for supermarket chain Supervalu, deputy director for institutional real estate for the Boston Redevelopment Authority, and a public finance specialist at the former Bank of Boston.

Hunter began his career as a strategic planner for the Governor’s Office of Economic Development in the administration of Michael Dukakis.

He earned a BA in political science from the College of the Holy Cross, and a master’s in management from the Heller School at Brandeis University.

Robert Wasserman Joins Dawson James Securities as Director of Research

Robert Wasserman has joined the brokerage and investment banking firm Dawson James Securities, as director of research.

Wasserman has covered pharmaceuticals, medical devices, healthcare services, and biotechnology during his more than 20 years of equity research, with a focus on companies in Florida and the rest of the Southeastern US.

Wasserman was the founder of the research effort at Dawson James, and has served as director of research for Jesup & Lamont, a senior research analyst for Craig-Hallum Capital Group, and vice president-research and partner for Southeast Research Partners/Ryan Beck. Earlier, Wasserman was a management consultant with Peat, Marwick, Mitchell & Co., a predecessor company to KPMG Peat Marwick.

Wasserman received his MBA degree in finance from the University of Chicago, and dual BSci degrees in management and engineering from the Massachusetts Institute of Technology.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.